Ilson D - Search Results

1

Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks.

Sharma S, Kemeny N, Schwartz GK, Kelsen D, O'Reilly E, Ilson D, Coyle J, De Jager RL, Ducharme MP, Kleban S, Hollywood E, Saltz LB. Sharma S, et al. Among authors: ilson d. Clin Cancer Res. 2001 Dec;7(12):3963-70. Clin Cancer Res. 2001. PMID: 11751488 Clinical Trial.

2

A phase II trial of interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma.

Ilson DH, Motzer RJ, Kradin RL, Vogelzang NJ, Bajorin DF, Scher HI, Nanus D, O'Moore P, Marathias K, Bosl GJ. Ilson DH, et al. J Clin Oncol. 1992 Jul;10(7):1124-30. doi: 10.1200/JCO.1992.10.7.1124. J Clin Oncol. 1992. PMID: 1607918 Clinical Trial.

3

The activity of paclitaxel in gastrointestinal tumors.

Ajani JA, Ilson DH, Kelsen DP. Ajani JA, et al. Among authors: ilson dh. Semin Oncol. 1995 Oct;22(5 Suppl 12):46-50; discussion 51-3. Semin Oncol. 1995. PMID: 7481861 Clinical Trial.

4

A phase II trial of paclitaxel (Taxol) in advanced esophageal cancer: preliminary report.

Kelsen D, Ajani J, Ilson D, Daugherty K, Pazdur R. Kelsen D, et al. Among authors: ilson d. Semin Oncol. 1994 Oct;21(5 Suppl 8):44-8. Semin Oncol. 1994. PMID: 7524158 Clinical Trial.

5

Paclitaxel in the treatment of carcinoma of the esophagus.

Ajani JA, Ilson DH, Daugherty K, Kelsen DP. Ajani JA, et al. Among authors: ilson dh. Semin Oncol. 1995 Jun;22(3 Suppl 6):35-40. Semin Oncol. 1995. PMID: 7541155 Clinical Trial.

6

A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.

Ilson DH, Sirott M, Saltz L, Heelan R, Huang Y, Keresztes R, Kelsen DP. Ilson DH, et al. Cancer. 1995 May 1;75(9):2197-202. doi: 10.1002/1097-0142(19950501)75:9<2197::aid-cncr2820750902>3.0.co;2-s. Cancer. 1995. PMID: 7712428 Clinical Trial.

7

Chemotherapy and combined-modality therapy for esophageal cancer.

Kelsen DP, Ilson DH. Kelsen DP, et al. Among authors: ilson dh. Chest. 1995 Jun;107(6 Suppl):224S-232S. doi: 10.1378/chest.107.6_supplement.224s. Chest. 1995. PMID: 7781398 Review.

8

Phase II trial of topotecan in patients with advanced renal cell carcinoma.

Law TM, Ilson DH, Motzer RJ. Law TM, et al. Among authors: ilson dh. Invest New Drugs. 1994;12(2):143-5. doi: 10.1007/BF00874445. Invest New Drugs. 1994. PMID: 7860232 Clinical Trial.

9

Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus.

Ajani JA, Ilson DH, Daugherty K, Pazdur R, Lynch PM, Kelsen DP. Ajani JA, et al. Among authors: ilson dh. J Natl Cancer Inst. 1994 Jul 20;86(14):1086-91. doi: 10.1093/jnci/86.14.1086. J Natl Cancer Inst. 1994. PMID: 7912736 Clinical Trial.

10

Adjuvant postoperative therapy of gastrointestinal malignancies.

Ilson DH, Kelsen DP. Ilson DH, et al. Oncology (Williston Park). 1994 Jul;8(7):75-83; discussion 83, 88-90, 95. Oncology (Williston Park). 1994. PMID: 7917843 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters